UNSPSC 51261802: Efaroxan

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51261802

Definition

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C13H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G00490L21H, chemically known as (+-)-2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline but generally known as efaroxan, which bears US NIH Compound Identifier 72016. European Medicines Agency schedules Efaroxan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06462MIG.

Read the full definition

The term EFAROXAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). EFAROXAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule efaroxan under HS 29349990 and SITC 51579. As of Q4 2014, EFAROXAN remains the US FDA Preferred Term for this commodity. Efaroxan bears US NLM identifiers UMLS ID C0058957 and NCI Concept Code C72923. SMILES: O1C(CC2C1CCCC2)(CC)C1=NCCN1.

About UNSPSC 51261802

UNSPSC 51261802 Efaroxan is a Commodity code that covers pharmaceutical products for emergency response and harm reduction, based on actual state and local procurement activity. State and local governments are buying naloxone (a life-saving opioid antagonist) and drug deactivation systems through this code. The issuing bodies include county health departments and state health and human services commissions soliciting these products to support community health, overdose response, and substance-use initiatives. The procurement instruments range from competitive sealed bids (IFB) for recurring supply contracts to exploratory requests for information (RFI) for larger program design.

Geographic activity centers on Florida and Texas in the recent record. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the response deadline was July 26, 2023, and the contract runs two years with a one-year renewal option on a fixed-fee basis with all shipping included in vendor proposals. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities and market intelligence on implementing a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program; the RFI closed April 3, 2026, and represents a preliminary information-gathering phase to inform a future formal RFP. Both solicitations require E-Verify compliance and drug-free workplace certification; the Seminole County contract includes a three-month probationary termination clause and potential FEMA funding with associated federal compliance requirements.

Quick answers

What is UNSPSC 51261802?

UNSPSC 51261802 is Efaroxan, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51261802?

UNSPSC 51261802 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51261802

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code